
#148 - Meet The Ibogaine Psychedelic Scientist Who First Unravelled Its Big Mystery
🧠JOIN THE GIANT’S SHOULDER FAMILY Become a YouTube Member for exclusive episodes, early access + ad-free viewing: https://www.youtube.com/@thegiantsshoulder/join Deborah Mash is a neuropharmacologist who holds the first FDA licence ever granted to give ibogaine to a human being, built one of America's largest brain banks, and discovered noribogaine — the metabolite now entering its first US clinical trial. She has spent over thirty years on a drug that appears to interrupt addiction after a single dose. This April a US president named it specifically. This is the scientist who was right three decades early. Expect to learn what Trump's executive order actually changes for ibogaine, why Sasha Shulgin put ibogaine in a box of its own, how noribogaine blocks nicotine, alcohol, cocaine and opioid use in animal models, why ibogaine holds the brain's neuroplasticity window open for four weeks when ketamine manages days, why some patients get the full therapeutic benefit with no psychedelic experience at all, why the reported ibogaine deaths are almost impossible to interpret, why more than 80% of her patients said they never wanted to repeat it, and much more...
Publisher
Giants Shoulder
Link
podcasters.spotify.com/pod/show/evanmcgloughlin/episodes/148---Meet-The-Ibogaine-Psychedelic-Scientist-Who-First-Unravelled-Its-Big-Mystery-e3njlfe
Published
August 20, 2026
Duration
1h 2m
Format
Podcast
Category
Issues · Science
Source
RSS feed
Host
Evan McGloughlin
Giants Shoulder
@giantsshoulder
#ibogainepsychedelicscientist #unravelled #bigmystery #lifesciences
